Learn More
This study was to investigate the safety and tolerability of ganitumab in Japanese patients with advanced solid tumors. Patients were enrolled into 1 of 3 dose cohorts (6, 12, or 20 mg/kg) of(More)
318 Background: AMG 479 is a fully human monoclonal antibody against human IGF-1R that inhibits the survival and proliferative signals driven by IGF-1 and -2. METHODS Patients (Pts) were enrolled(More)